Therefore, we suggest that sildenafil abolishes DOX–induced activation of NF-κB, which also down-regulates FAP-1 and c-FLIP and stimulates CD95-mediated apoptosis in prostate cancer cells. Here, CFLAR is linked to prostate cancer.